SciSparc Ltd. (SPRC)
NASDAQ: SPRC · Real-Time Price · USD
4.980
+0.270 (5.73%)
Jul 7, 2026, 4:00 PM EDT - Market closed
SciSparc Revenue
In the year 2025, SciSparc had annual revenue of $856.00K, down -34.46%. SciSparc had revenue of $856.00K in the quarter ending December 31, 2025, a decrease of -34.46%.
Revenue (ttm)
$856.00K
Revenue Growth
-34.46%
P/S Ratio
3.33
Revenue / Employee
$285,333
Employees
3
Market Cap
2.85M
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 856.00K | -450.00K | -34.46% |
| Dec 31, 2024 | 1.31M | -1.57M | -54.64% |
| Dec 31, 2023 | 2.88M | 1.53M | 113.73% |
| Dec 31, 2022 | 1.35M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSPRC News
- 5 days ago - NeuroThera Labs Announces Upsize to Private Placement - TheNewswire
- 7 days ago - NeuroThera Labs Announces C$5,000,000 Private Placement of Units - TheNewswire
- 4 weeks ago - SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum - GlobeNewsWire
- 4 weeks ago - Neurothera Labs Inc. Announces Closing Of Acquisition Of Majority Stake In Cliniquantum Ltd. - TheNewswire
- 5 weeks ago - SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum - GlobeNewsWire
- 6 weeks ago - Neurothera Labs Announces Adoption of Semi-Annual Reporting - TheNewswire
- 2 months ago - Neurothera Labs Announces Continuance into Ontario - TheNewswire
- 2 months ago - Neurothera Labs Engages bullVestor for Investor Relations Activities - TheNewswire